Amwell expects Q4 2026 revenue of $48M-$50M and adjusted EBITDA from breakeven to $1M (NYSE:AMWL)

Amwell Q3 2026 earnings: raised guidance, Q4 EBITDA breakeven target, and VA/DHA contract updates.

Continue in Briflio to read, react, comment, and share.